Literature DB >> 20136635

Formation of transient dimers by a retroviral protease.

Maximilian J Hartl1, Kristian Schweimer, Martin H Reger, Stephan Schwarzinger, Jochen Bodem, Paul Rösch, Birgitta M Wöhrl.   

Abstract

Retroviral proteases have been shown previously to be only active as homodimers. They are essential to form the separate and active proteins from the viral precursors. Spumaretroviruses produce separate precursors for Gag and Pol, rather than a Gag and a Gag-Pol precursor. Nevertheless, processing of Pol into a PR (protease)-RT (reverse transcriptase) and integrase is essential in order to obtain infectious viral particles. We showed recently that the PR-RT from a simian foamy virus, as well as the separate PRshort (protease) domain, exhibit proteolytic activities, although only monomeric forms could be detected. In the present study, we demonstrate that PRshort and PR-RT can be inhibited by the putative dimerization inhibitor cholic acid. Various other inhibitors, including darunavir and tipranavir, known to prevent HIV-1 PR dimerization in cells, had no effect on foamy virus protease in vitro. 1H-15N HSQC (heteronuclear single quantum coherence) NMR analysis of PRshort indicates that cholic acid binds in the proposed PRshort dimerization interface and appears to impair formation of the correct dimer. NMR analysis by paramagnetic relaxation enhancement resulted in elevated transverse relaxation rates of those amino acids predicted to participate in dimer formation. Our results suggest transient PRshort homodimers are formed under native conditions but are only present as a minor transient species, which is not detectable by traditional methods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136635     DOI: 10.1042/BJ20091451

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Foamy virus Pol protein expressed as a Gag-Pol fusion retains enzymatic activities, allowing for infectious virus production.

Authors:  Eun-Gyung Lee; Amber Sinicrope; Dana L Jackson; Shuyuarn F Yu; Maxine L Linial
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

Review 2.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

3.  Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation.

Authors:  Eun-Gyung Lee; Jacqueline Roy; Dana Jackson; Patrick Clark; Paul L Boyer; Stephen H Hughes; Maxine L Linial
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Mapping the encounter state of a transient protein complex by PRE NMR spectroscopy.

Authors:  Alexander N Volkov; Marcellus Ubbink; Nico A J van Nuland
Journal:  J Biomol NMR       Date:  2010-11-04       Impact factor: 2.835

5.  Regulation of foamy virus protease activity by viral RNA: a novel and unique mechanism among retroviruses.

Authors:  Maximilian J Hartl; Jochen Bodem; Fabian Jochheim; Axel Rethwilm; Paul Rösch; Birgitta M Wöhrl
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

6.  Retroviral DNA Transposition: Themes and Variations.

Authors:  Anna Marie Skalka
Journal:  Microbiol Spectr       Date:  2014-12

Review 7.  Foamy virus biology and its application for vector development.

Authors:  Dirk Lindemann; Axel Rethwilm
Journal:  Viruses       Date:  2011-05-11       Impact factor: 5.048

8.  AZT resistance alters enzymatic properties and creates an ATP-binding site in SFVmac reverse transcriptase.

Authors:  Anna Schneider; Kristian Schweimer; Paul Rösch; Birgitta M Wöhrl
Journal:  Retrovirology       Date:  2015-02-22       Impact factor: 4.602

9.  The prototype foamy virus protease is active independently of the integrase domain.

Authors:  Ralf Spannaus; Maximilian J Hartl; Birgitta M Wöhrl; Axel Rethwilm; Jochen Bodem
Journal:  Retrovirology       Date:  2012-05-10       Impact factor: 4.602

Review 10.  Foamy virus assembly with emphasis on pol encapsidation.

Authors:  Eun-Gyung Lee; Carolyn R Stenbak; Maxine L Linial
Journal:  Viruses       Date:  2013-03-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.